It looks to me that Kimberly Clark (UK) are targeting the $3B transdermal patch market using imprint technology in a new development program with imprint supplier – Obducat (Sweden). Kimberly-Clark is ...
Nutriband files provisional patent application to enhance its AVERSA™ transdermal abuse deterrent technology being developed for patches containing opioids and stimulants with a potential for abuse.
DUBLIN--(BUSINESS WIRE)--The "Global Transdermal Patches Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering. The global transdermal patches market is ...
Although antigen-specific autoimmunity is thought to play a critical role in the pathogenesis of multiple sclerosis, all currently available therapies reduce global immune function without targeting ...
Minimize reactions to transdermal patches Applying triamcinolone prior to a transdermal patch helps prevent contact dermatitis. If a patient has a mild reaction to the adhesive on a transdermal patch, ...
Noven Submits New Drug Application for Investigational Dextroamphetamine Transdermal System for ADHD
MIAMI & JERSEY CITY, N.J.--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc., (“Noven”) a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today confirmed it has submitted a New Drug ...
Daytrana (methylphenidate) is a prescription drug that’s used to treat attention deficit hyperactivity disorder (ADHD). It comes as a transdermal patch that’s usually applied to the skin once per day.
Many refer to topicals as the "gateway drug" to cannabis. Feeling external relief without a psychedelic high is a low-risk entry point, and the subtle jars or small bottles make them easier to stick ...
Forbes contributors publish independent expert analyses and insights. Peter Cohan, a Boston-based senior contributor, covers stocks. Eight years ago, I wrote about a startup trying to deliver cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results